# MorphoSys

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/morphosys/

## Facts

| Field | Value |
| --- | --- |
| Country | DE |
| Description | German biopharmaceutical company |
| OpenAlex ID | https://openalex.org/F4320328062 |
| ROR ID | https://ror.org/00ew7rg06 |
| Works | 889 |

## Funder papers

- [Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases](https://scholariq.org/papers/executive-summary-of-the-kdigo-2021-guideline-for-the-management-of-glomerular/)
- [New Treatment Strategies for IgA Nephropathy: Targeting Plasma Cells as the Main Source of Pathogenic Antibodies](https://scholariq.org/papers/new-treatment-strategies-for-iga-nephropathy-targeting-plasma-cells-as-the-main/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.